0
0
ATLANTA — In a move that medical experts say dismantles decades of public health progress, a federal advisory panel appointed by Health and Human Services Secretary Robert F. Kennedy Jr. has voted to eliminate the long-standing recommendation that all newborns receive the hepatitis B vaccine. The decision, reached in an 8-3 vote on Friday, overturns a standard of care established in 1991 that is credited with nearly eradicating the virus among American children.
Infectious disease specialists and pediatric organizations immediately condemned the move, warning that it “turns back the clock” on disease prevention and leaves infants vulnerable to a potentially fatal liver infection.
The Decision: Ending Universal Coverage
The Advisory Committee on Immunization Practices (ACIP), which advises the Centers for Disease Control and Prevention (CDC) on vaccine usage, voted to rescind the universal birth dose recommendation. Under the new guidance, the vaccine is explicitly recommended at birth only for infants born to mothers who test positive for hepatitis B or whose infection status is unknown.
For the majority of infants born to mothers who test negative, the panel recommends that parents engage in “shared clinical decision-making” with their providers to determine if and when to begin the vaccination series, effectively suggesting a delay until the child is at least two months old.
The committee’s rationale, voiced by members aligned with Secretary Kennedy’s skeptical stance on established vaccine schedules, posits that the risk of infection for most newborns is low and that the previous policy was “overly broad.” Robert Malone, the panel’s vice chair, supported the revision, arguing for increased parental choice over universal mandates.
Expert Backlash: “Turning Back the Clock”
The medical community’s reaction has been swift and severe. Critics argue that the panel’s decision ignores the reality of how hepatitis B is transmitted and the limitations of maternal screening.
“They’ve turned back the clock to pre-1991,” said Dr. William Schaffner, an infectious diseases specialist at Vanderbilt University and a former ACIP member. “Some of these committee members would indeed be pleased if some parents chose never to vaccinate their children against hepatitis B.”
The primary concern among experts is that testing mothers is not a foolproof safeguard. Tests can yield false negatives, and mothers can contract the virus after testing but before delivery. Furthermore, hepatitis B can be transmitted from infected household members or caregivers other than the mother—a risk that the universal birth dose effectively neutralizes.
“We will see hepatitis B infections come back,” warned Dr. Cody Meissner, a professor of pediatrics at Dartmouth and one of the three committee members who voted against the change. “The vaccine is so effective, it does not make sense in my mind to change the immunization schedule.”
The Science: A Legacy of Success
Prior to 1991, the U.S. strategy focused on vaccinating only high-risk groups, a targeted approach that failed to halt the spread of the virus. It was only after the adoption of the universal birth dose that infection rates among children plummeted by more than 95%, according to CDC data.
Hepatitis B is a viral infection that attacks the liver. While often asymptomatic in infants, it is far more dangerous for them than for adults. Approximately 90% of infants infected with hepatitis B will develop a chronic, lifelong infection, significantly increasing their risk of cirrhosis, liver failure, and liver cancer later in life.
“The science is clear: the hepatitis B birth dose saves lives,” stated the American Pharmacists Association in a press release. “There is no new evidence to justify delaying or removing this critical protection.”
Implications for Public Health
The shift to “shared clinical decision-making” introduces a layer of complexity that experts fear will widen health disparities.
-
Insurance and Access: While major insurers have not yet indicated they will drop coverage, the removal of a firm CDC recommendation gives them the latitude to do so. This could leave low-income families with fewer options.
-
Confusion for Parents: By framing the vaccine as optional or negotiable, the committee may inadvertently signal that the vaccine is unnecessary or unsafe, despite decades of safety data.
-
The “Slippery Slope”: This vote is viewed by many as a harbinger of broader changes. The panel has indicated plans to review the entire childhood immunization schedule, a move Dr. Flor Munoz of Texas Children’s Hospital described as “dismantling the vaccine schedule.”
“What they are really doing is dismantling the vaccine schedule,” Munoz told reporters. “Every other vaccine is probably going to fall under their plan.”
Context: A Reconstituted Panel
The vote underscores the profound shift in federal health policy under Secretary Kennedy. Earlier this year, Kennedy dismissed the previous ACIP members—typically independent experts in vaccinology and immunology—and replaced them with individuals who share his critical views on the pharmaceutical industry and current vaccine practices.
The decision now rests with the acting director of the CDC. While CDC directors typically accept ACIP recommendations, the current political climate and the panel’s alignment with HHS leadership suggest the change is likely to be adopted as official policy.
Medical Disclaimer
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
References
-
Primary Report: Reuters. (2025, December 7). Kennedy vaccine advisers ‘turned back the clock’ on disease prevention, experts say.
